| 0.0304 0.002 (8.19%) | 05-12 15:45 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.04  |
1-year : | 0.05 |
| Resists | First : | 0.03 |
Second : | 0.04 |
| Pivot price | 0.03 |
|||
| Supports | First : | 0.02 | Second : | 0.02 |
| MAs | MA(5) : | 0.03 |
MA(20) : | 0.03 |
| MA(100) : | 0.04 |
MA(250) : | 0.05 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 17.4 |
D(3) : | 36 |
| RSI | RSI(14): 40.3  |
|||
| 52-week | High : | 0.21 | Low : | 0.02 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AFIB ] has closed above bottom band by 23.0%. Bollinger Bands are 4.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.03 - 0.03 | 0.03 - 0.03 |
| Low: | 0.03 - 0.03 | 0.03 - 0.03 |
| Close: | 0.03 - 0.03 | 0.03 - 0.03 |
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Thu, 17 Oct 2024
Acutus Medical finalizes settlement with Biotronik, ends agreements - Investing.com
Sat, 11 May 2024
AFIB Stock Price and Chart — OTC:AFIB - TradingView
Wed, 08 Nov 2023
Acutus Medical is laying off more than half of its workers - MassDevice
Thu, 10 Nov 2022
Acutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates - Yahoo News UK
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 30 (M) |
| Shares Float | 27 (M) |
| Held by Insiders | 9 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 554 (K) |
| Shares Short P.Month | 985 (K) |
| EPS | -0.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.16 |
| Profit Margin | 0 % |
| Operating Margin | -62.3 % |
| Return on Assets (ttm) | -14 % |
| Return on Equity (ttm) | -30 % |
| Qtrly Rev. Growth | 172.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.4 |
| EBITDA (p.s.) | -0.51 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -56 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -0.16 |
| PEG Ratio | 0 |
| Price to Book value | -0.2 |
| Price to Sales | 0.07 |
| Price to Cash Flow | -0.02 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|